Manual

Product Number: DTK582

Shipping and Storage

-20℃ ±5℃, store and transport away from light, with no more than 5 freeze-thaw cycles, and a shelf life of 12 months.

Component

Note: Different batches of reagents cannot be mixed.

Description

In China, cytomegalovirus (CMV) infection is widely prevalent, with many healthy individuals harboring the virus in a latent state. However, most immunocompetent individuals exhibit asymptomatic infections. CMV infections are more common in fetuses, newborns, pregnant women, and immunocompromised individuals. Maternal infection can lead to congenital or perinatal CMV transmission, resulting in fetal malformations, intellectual disabilities, or developmental delays. In severe cases, systemic infection syndrome may occur. When the immune system is compromised or suppressed—such as in patients with tumors, organ transplants, or acquired immunodeficiency syndrome—primary CMV infection or reactivation of latent infection often causes various opportunistic infections with high fatality rates. This kit is designed for in vitro detection of CMV nucleic acid in human serum or urine samples.

This kit is suitable for detecting human cytomegalovirus nucleic acid in human serum or urine samples, and can be used for the auxiliary diagnosis of human cytomegalovirus infection and the efficacy monitoring of antiviral drug treatment. The test results are for reference only and cannot be used alone as a basis for confirming or ruling out cases.

Application

This kit is designed with CMV-specific primers and probes based on the CMV viral gene. It employs fluorescence PCR technology to amplify and detect CMV viral nucleic acids in vitro, serving for the etiological diagnosis of suspected infections in clinical settings.

Get a quote